Search Results - "Scattolin, Anna Maria"
-
1
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Published in Blood (30-04-2009)“…Clinical risk classification is inaccurate in predicting relapse in adult patients with acute lymphoblastic leukemia, sometimes resulting in patients receiving…”
Get full text
Journal Article -
2
-
3
COVID-19 Infection in acute lymphoblastic leukemia over 15 months of the pandemic. A CAMPUS ALL report
Published in Haematologica (Roma) (01-08-2022)Get full text
Journal Article -
4
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
Published in Blood cancer journal (New York) (13-11-2020)“…An updated strategy combining pediatric-based chemotherapy with risk-oriented allogeneic hematopoietic cell transplantation (HCT) was evaluated in Philadelphia…”
Get full text
Journal Article -
5
Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV
Published in Hematological oncology (01-12-2022)“…The impact of secondary infections (SI) on COVID‐19 outcome in patients with hematological malignancies (HM) is scarcely documented. To evaluate incidence,…”
Get full text
Journal Article -
6
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program
Published in Haematologica (Roma) (01-11-2013)“…We evaluate the long-term results of a prospective clinical study enrolling more than 100 adult patients with Burkitt lymphoma/leukemia. Depending on extent of…”
Get full text
Journal Article -
7
-
8
Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells
Published in Mediterranean journal of hematology and infectious diseases (2015)“…The introduction of newer cytotoxic monoclonal antibodies and chimeric antigen receptor modified T cells is opening a new age in the management of B-lineage…”
Get full text
Journal Article -
9
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia
Published in Mediterranean journal of hematology and infectious diseases (01-01-2014)“…Acute lymphoblastic leukemia (ALL) is curable in about 40-50% of adult patients, however this is subject to ample variations owing to several host- and…”
Get full text
Journal Article -
10
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Published in The Lancet. Haematology (01-10-2020)“…Several small studies on patients with COVID-19 and haematological malignancies are available showing a high mortality in this population. The Italian…”
Get full text
Journal Article -
11
Current and future management of Ph/BCR-ABL positive ALL
Published in Expert review of anticancer therapy (01-06-2014)“…Following the introduction of targeted therapy with tyrosine kinase inhibitors (TKI) at the beginning of the past decade, the outcome of patients with…”
Get full text
Journal Article -
12
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study
Published in British journal of haematology (01-02-2023)“…Summary Within the Campus ALL network we analyzed the incidence, characteristics, treatment and outcome of a central nervous system (CNS) relapse in 1035…”
Get full text
Journal Article -
13
CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program
Published in Blood (23-11-2021)“…Introduction: The outcome of patients with acute myeloid leukemia (AML) secondary to myelodisplastic syndrome (MDS) or therapy-related (t-AML) receiving…”
Get full text
Journal Article -
14
ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report
Published in Blood (23-11-2021)“…▪ Introduction. The recent spread of the COVID-19 infection has represented an important challenge in the management of acute lymphoblastic leukemia (ALL)…”
Get full text
Journal Article -
15
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
Published in Blood cancer journal (New York) (06-10-2020)“…Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and allogeneic stem cell transplantation (HSCT). We evaluated toxicity and…”
Get full text
Journal Article -
16
Immunotherapy approaches to treat adult acute lymphoblastic leukemia
Published in Expert review of hematology (02-06-2016)“…Recent developments in immunotherapy are improving treatment results of B-precursor acute lymphoblastic leukemia. This advancement is promoted by new…”
Get more information
Journal Article -
17
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
Published in Haematologica (Roma) (27-08-2020)“…Secondary acute myeloid leukemia (sAML) after myelodysplastic or myeloproliferative disorders is a high-risk category currently identified by clinical history…”
Get full text
Journal Article -
18
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06
Published in Blood (13-11-2019)“…Introduction Patients with secondary acute myeloid leukemia (sAML) after myelodysplastic (MDS) or myeloproliferative neoplasms (MPN) treated with chemotherapy…”
Get full text
Journal Article -
19
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol
Published in Leukemia & lymphoma (06-12-2019)“…Clofarabine (CLO) and cyclophosphamide (CY) combinations were tested in late stage refractory/relapsed (R/R) acute lymphoblastic leukemia (ALL) with…”
Get full text
Journal Article -
20
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
Published in Blood advances (22-08-2023)“…•An improved pegaspargase-modified MRD and risk-oriented regimen was prospectively tested in adults aged 18-65 years with Ph– ALL/LL.•Three-year survival rates…”
Get full text
Journal Article